1380316-05-1 Usage
Description
SCG0928 is a synthetic nonsteroidal anti-inflammatory drug (NSAID) that functions by inhibiting the activity of cyclooxygenase (COX) enzymes, thereby reducing the production of prostaglandins. This action results in the drug's anti-inflammatory, analgesic, and antipyretic effects, making it a candidate for therapeutic applications in managing various inflammatory conditions.
Uses
Used in Pharmaceutical Industry:
SCG0928 is used as an anti-inflammatory agent for its ability to reduce inflammation by inhibiting COX enzymes, which is essential in the treatment of conditions like arthritis.
Used in Pain Management:
SCG0928 is utilized as an analgesic to alleviate pain by decreasing the production of prostaglandins that are responsible for pain sensation.
Used in Treatment of Fever:
SCG0928 serves as an antipyretic agent to reduce fever by lowering the body's temperature set point, providing relief in conditions characterized by elevated body temperatures.
Used in Research and Development:
SCG0928 is applied in preclinical studies for its potential therapeutic applications in treating various inflammatory conditions, with ongoing research to evaluate its safety and efficacy in human subjects.
Check Digit Verification of cas no
The CAS Registry Mumber 1380316-05-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,0,3,1 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1380316-05:
(9*1)+(8*3)+(7*8)+(6*0)+(5*3)+(4*1)+(3*6)+(2*0)+(1*5)=131
131 % 10 = 1
So 1380316-05-1 is a valid CAS Registry Number.
1380316-05-1Relevant articles and documents
7-DEAZAPURINE MODULATORS OF HISTONE METHYLTRANSFERASE, AND METHODS OF USE THEREOF
-
Page/Page column 97, (2012/06/16)
Disclosed are compounds, pharmaceutical compositions containing the compounds, uses of the compounds and compositions as modulators of histone methyltransf erases, and methods for treating diseases influenced by modulation of histone methyltransferase activity.
